GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanosphere Health Sciences Inc (XCNQ:NSHS) » Definitions » Capex-to-Operating-Income

Nanosphere Health Sciences (XCNQ:NSHS) Capex-to-Operating-Income : 0.00 (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Nanosphere Health Sciences Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Nanosphere Health Sciences's Capital Expenditure for the three months ended in Sep. 2024 was C$0.00 Mil. Its Operating Income for the three months ended in Sep. 2024 was C$-0.06 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Nanosphere Health Sciences Capex-to-Operating-Income Historical Data

The historical data trend for Nanosphere Health Sciences's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere Health Sciences Capex-to-Operating-Income Chart

Nanosphere Health Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nanosphere Health Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nanosphere Health Sciences's Capex-to-Operating-Income

For the Biotechnology subindustry, Nanosphere Health Sciences's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanosphere Health Sciences's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Nanosphere Health Sciences's Capex-to-Operating-Income falls into.



Nanosphere Health Sciences Capex-to-Operating-Income Calculation

Nanosphere Health Sciences's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.318
=N/A

Nanosphere Health Sciences's Capex-to-Operating-Income for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.064
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanosphere Health Sciences  (XCNQ:NSHS) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Nanosphere Health Sciences Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Nanosphere Health Sciences's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosphere Health Sciences Business Description

Traded in Other Exchanges
Address
1090 West Georgia Street, Suite 488, Vancouver, BC, CAN, V6E 3V7
Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicants through licensing arrangements.

Nanosphere Health Sciences Headlines

No Headlines